TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United ...

October 10, 2024--Tredegar Surface Protection, a subsidiary of Tredegar Corporation (NYSE:TG) and a leader in high-quality masking films, is excited to announce the launch of Obsidian Automotive ...

Three principal thyroid autoantigens are involved in AITD. These are thyroperoxidase (TPO), thyroglobulin (Tg) and the TSH receptor. Other autoantigens, such as the Sodium Iodide Symporter (NIS ...